TV 5010

Drug Profile

TV 5010

Latest Information Update: 10 Mar 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Teva Pharmaceutical Industries
  • Class Amino acids; Peptides
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Crohn's disease; Multiple sclerosis; Neurological disorders

Most Recent Events

  • 31 Dec 2006 Discontinued - Phase-II for Crohn's disease in Israel (SC)
  • 31 Dec 2006 Discontinued - Phase-II for Multiple sclerosis in Europe (SC)
  • 15 Jun 2006 Phase-II clinical trials in Crohn's disease in Israel (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top